TORONTO, ON / ACCESSWIRE / September 20, 2024 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announces that further to its news releases dated August 23, 2024, August 29, ...

IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to ...

Increase in Year Over Year Revenue Growth and a 9% increase in Gross profit DENVER, CO / ACCESSWIRE / September 20, 2024 / Leafbuyer Technologies Inc. ("Leafbuyer" or "the Company") (OTCQB:LBUY), a ...

Dr. Paul Vitenas Unveils 'Yoga Boobs' Trend for Natural, Athletic Breast Augmentation Using Cutting-Edge TechniquesHOUSTON, TX / ACCESSWIRE / September 20, 2024 / Dr. Paul Vitenas, a board-certified ...

SAN DIEGO, CA / ACCESSWIRE / September 20, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care ...

Nutriband signs trademark licensing agreement for Bitrex® brand denatonium benzoate, the most bitter substance in the world, as an aversive agent for its Aversa™ Fentanyl abuse deterrent fentanyl ...

The sam® wearable ultrasound biotechnology is purpose-built to treat the most common athletic injuries, accelerating soft tissue healing and reducing the need for surgery or pain medication.TRUMBULL, ...

LIPID inCode tests patients to identify familial hypercholesterolemia and prevent cardiovascular diseaseOXFORD, ENGLAND / ACCESSWIRE / September 20, 2024 / GENinCode Plc (AIM:GENI), the genetics ...

The global healthcare landscape is undergoing a profound transformation with the emergence of virtual hospitals, a paradigm ...

Each year, the CDC estimates that around 385,000 healthcare workers in the United States suffer from needlestick and ...

Dr. Paulo Fontoura, MD, PhD, joins STALICLA as Chief Scientific and Clinical Development Advisor Geneva, Switzerland – September 19, 2024 – STALICLA SA, a Swiss neuro precision biotech company ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix ...